Wound Care

According to a recent review, application of a single-use negative pressure wound therapy system reduced the rate of SSI by 58% compared to standard of care. Additionally, patients had less hospital LOS compared to standard of care.[1]

RadiaLux™

The Genadyne NPWT portfolio is completely comprehensive, from Ultraportable Single-Use and Reusable Pumps to High Demand and Instil Pumps. The Dressing Portfolio is compatible across all NPWT Pumps, allowing for an all-inclusive ecosystem for a hospital institution. From Absorbent Dressings that can be used with or without NPWT, ready to use Foam Dressings, and all the way to large Foam Kits, Abdominal Kits and PVA Kits.

Closed incision management negative pressure has been proven to:

  • Protect the incision from external contamination
  • Hold closed incision wound edges together
  • Help reduce tensile forces across the incision
  • Help reduce oedema
  • Reduce seroma and haematoma fluid collection
  • Suitable for dehisced wounds, trauma wounds, partial thickness burns, flaps and grafts

Green Foam

More than just a colour…

The visual impact of the Genadyne Green Foam is undeniable. Green was chosen to allow clinicians to better differentiate between viable and nonviable tissue in the wound bed. The colour contrast increases differentiation with the wound bed.

RadiaLux™

Competitor

RadiaLux™

Patented Genadyne Green Foam

  • Genadyne Green Foam is a fully reticulated polyurethane foam made with polyether resin to allow better hydrolytic stability. The design increases performance under pressure and in moist environments.
  • The Dodecahedron cell structure gives a three-dimensional skeletal strand to the cells providing enhanced filtering qualities and increasing the removal of exudate and infectious materials. This cell structure also increases tensile strength to prevent fraying. Fraying is significantly reduced, preventing stray pieces from being left in the wound bed.
  • The combination of cell structure and composition gives the foam a non-adherent property, allowing for easier removal during dressing changes, thereby reducing pain and discomfort.
  • The foam creates direct contact with the wound bed, allowing for even distribution of pressure. This assists in reducing oedema and promotes tissue perfusion and granulation.

Properties

Benefits

Fully reticulated polyurethane foam

Increased hydrolytic stability

Polyether resin

Increased tensile strength

Pore Size

Boosts performance under pressure

Dodecahedron cell structure / 3 dimensional skeletal strands

Enhanced filtering qualities
Increased tensile strength
Reduced risk of fraying
Non-adherent properties
Reduced discomfort during dressing change

Variable Pressure

The advanced variable pressure capabilities of all of the Genadyne Negative Pressure Pumps, allow different negative pressures to be used without the downsides of painful intermittent therapy.

By maintaining negative pressure throughout the cycle, variable negative pressure wound therapy avoids losing an airtight seal and displacement of the dressing. This gradual “wave” is gentler to the patient increasing blood flow to the peri-wound and preventing ischemia. The changes in pressure are imperceptible to the patient, increasing patient comfort and compliance.

The literature suggests that the use of Variable Pressure is beneficial. It results in decreased blood flow that is known to stimulate angiogenesis and granulation tissue formation and to increase blood flow that is known to facilitate oxygenation and nutrient supply and removal of waste products. [2]

Cycling the negative pressure level may be beneficial especially when treating poorly vascularized tissue with a risk for development of ischemia, as pressure is released repeatedly.[2]

Image
  • It is estimated that 2% to 5% of all patients who undergo surgery will develop a Surgical Site Infection (SSI). These infections are associated with added morbidity, including prolonged hospitalisation by 2 weeks, 5 times the risk of readmission, an increase in average health care costs of up to $26,000 per patient, and twice the risk of death.[1]
FloraSeal®
  • FloraSeal has been shown to trap and immobilise bacteria that may cause infection to the patient. It rapidly and powerfully kills gram-positive and gram-negative bacteria.[2]
  • FloraSeal effectively reduces microbial colonisation within 15 minutes and maintains a low microbial colonisation throughout the 24 hours after application, has the same efficacy when being used with or without an antimicrobial surgical incise drape, and mitigates microorganisms more effectively than an antimicrobial surgical incise drape alone.[3]

1. Towfigh, S., Cheadle, W. G., Lowry, S. F., Malangoni, M. A., & Wilson, S. E. (2008). Significant reduction in incidence of wound contamination by skin flora through use of microbial sealant. Archives of surgery (Chicago, Ill.:1960), 143(9), 885–891.

2. Prince, D., Kohan, K., Solanki, Z., Mastej, J., Prince, D., Varughese, R., & Patel, M. (2017). Immobilization and death of bacteria by Flora Seal microbial sealant. Int J Pharm Sci Invent, 6(6), 45-49.

3. Data on File. HB Fuller - Medical Adhesives Technology

SurgiSeal® Topical Skin Adhesive is a high purity, antimicrobial, liquid topical skin adhesive that can replace sutures for incision or laceration repair.

SurgiSeal® is the only topical skin adhesive in the world to receive FDA 510K Clearance in demonstrating inhibition of gram-positive and gram-negative bacteria growth.[1]

SurgiSeal® provides the optimal balance between strength and flexibility. In replacing sutures for incision or laceration repair, it can save time, provide a flexible, water-resistant, protective coating, and eliminate the need for suture removal.

FloraSeal®

1. SurgiSeal IFU: Due to the anhydrous property of the SurgiSeal adhesive, gram+ and gram- bacteria which become incorporated within the adhesive upon application, are not expected to grow.

Synvichor is the world’s first genomic PCR test that sets a new medical standard globally for the rapid, accurate and reliable differentiation of joint pain.

Image

Undifferentiated joint pain: a global problem

When a patient presents with a red, hot, swollen and painful joint, reliably differentiating infection from inflammation poses a significant global problem.

Typical wait times for culture results vary from 24hrs to 21 days, with a true positivity of up to 20%, meaning they are inconclusive more than 80% of the time.

Rather than risk missing or misdiagnosing an infection, the current approach sees the patient admitted to hospital and treated with antibiotics.

This results in uncertainty for patients and clinicians, increased costs to the hospital, and poorer outcomes.

Unparalleled speed, precision, and reliability

With up to 95% negative and positive predictive value and results in ~3 hours, Synvichor provides rapid and reliable differentiation of joint pain.

Synvichor helps to rapidly assess which patients require urgent treatment for infection, and which patients can be safely managed in the community for non-infectious inflammation.

Synvichor logo

Enhances your diagnostic speed


Optimises your treatment options


Enables clinicians to safely manage up to two-thirds of patients in the community

Image

RAPID RESULTS

Synvichor logo

~ 3 hours

vs current culture testing

24 hours - 21 days

Image

RELIABLE PRECISION

Synvichor logo

UP TO

95%

ACCURACY

vs current culture testing

13-20% accuracy[1]

2. Graue C et al. Open Forum Infect Dis. 2020; 7(Suppl 1):S233–4.

Revolution Surgical Pty Ltd
4/22 Rowood Road, Prospect NSW 2148
ABN: 63 165 643 434

© 2018-2024 Revolution Surgical

Website by: WebInjection